bioMerieux Opens a Subsidiary in the Middle East, Continuing its International Growth
"This new subsidiary will be the hub for our Middle East commercial team. With 20,000 healthcare professionals in Dubai HealthCare City and international centers of excellence such as Harvard Medical School and Mayo Clinic, there are exciting opportunities in the UAE health economy," said Stéphane Bancel, Chief Executive Officer of bioMérieux. "bioMérieux’s solid business model allows us to continue our international expansion, a key factor for future growth and sales diversification."
Dubai HealthCare City, where the bioMérieux subsidiary is located, has the ambition of becoming the leading center in the region, filling a gap in healthcare services in the zone between Europe and Southeast Asia. bioMérieux will bring, in particular, its expertise as a world leader in diagnostics for healthcare associated infections (HAI) to local hospitals and universities to build HAI management programs.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.